Mostrar registro simples

dc.contributor.authorGuaragna Filho, Guilhermept_BR
dc.contributor.authorCalixto, Antônio Ramospt_BR
dc.contributor.authorAstur, Anna Beatriz Lima do Vallept_BR
dc.contributor.authorPaula, Georgette Beatriz dept_BR
dc.contributor.authorOliveira, Laurione Cândido dept_BR
dc.contributor.authorMorcillo, André Morenopt_BR
dc.contributor.authorGonçalves, Ezequiel Moreirapt_BR
dc.contributor.authorMello, Maricilda Palandi dept_BR
dc.contributor.authorGuerra, Andrea Trevas Macielpt_BR
dc.contributor.authorGuerra Júnior, Gilpt_BR
dc.date.accessioned2022-12-24T05:05:32Zpt_BR
dc.date.issued2022pt_BR
dc.identifier.issn1516-3180pt_BR
dc.identifier.urihttp://hdl.handle.net/10183/253172pt_BR
dc.description.abstractBACKGROUND: Because normal male sexual differentiation is more complex than normal female sexual differentiation, there are more cases of disorders of sex development (DSDs) with 46,XY karyotype that have unclear etiology. However, Leydig and Sertoli cell markers are rarely used in distinguishing such individuals. OBJECTIVES: To evaluate the function of Leydig and Sertoli cells in individuals with genital ambiguity, 46,XY karyotype, palpable gonads and normal testosterone secretion. STUDY DESIGN AND SETTING: Case-control study with 77 patients, including eight with partial androgen insensitivity syndrome, eight with 5α-reductase deficiency type 2 (5ARD2) and 19 with idiopathic 46,XY DSD, and 42 healthy controls, from the Interdisciplinary Study Group for Sex Determination and Differentiation (GIEDDS), at the State University of Campinas (UNICAMP), Campinas, Brazil. METHODS: Baseline levels of gonadotropins, anti-Müllerian hormone (AMH), inhibin B, insulin-like 3 (INSL3), testosterone and dihydrotestosterone in cases, and AMH, inhibin B, and INSL3 levels in controls, were assessed. RESULTS: There was no significant difference in age between cases and controls (P = 0.595). AMH and inhibin B levels were significantly lower in cases than in controls (P = 0.031 and P < 0.001, respectively). INSL3 levels were significantly higher in cases than in controls (P = 0.003). Inhibin B levels were lower in 5ARD2 patients (P = 0.045) and idiopathic patients (P = 0.001), in separate comparisons with the controls. CONCLUSION: According to our findings, we can speculate that inhibin B levels may be used to differentiate among DSD cases.en
dc.format.mimetypeapplication/pdfpt_BR
dc.language.isoengpt_BR
dc.relation.ispartofSão Paulo medical journal. São Paulo. Vol. 140, no. 2 (Mar./Apr. 2022), p. 163-170pt_BR
dc.rightsOpen Accessen
dc.subjectInibinaspt_BR
dc.subjectInhibin Ben
dc.subjectDisorders of sex developmenten
dc.subjectTranstornos do desenvolvimento sexualpt_BR
dc.subjectCélulas de Sertolipt_BR
dc.subjectSertoli cellsen
dc.subjectLeydig cellsen
dc.subjectCélulas intersticiais do testículopt_BR
dc.subjectSomatomedinaspt_BR
dc.subjectDSDen
dc.subjectAmbiguous genitalien
dc.subjectHormônio antimüllerianopt_BR
dc.subjectINSL3en
dc.subjectAMHen
dc.titleLeydig and Sertoli cell function in individuals with genital ambiguity, 46,XY karyotype, palpable gonads and normal testosterone secretion : a case-control studypt_BR
dc.typeArtigo de periódicopt_BR
dc.identifier.nrb001156820pt_BR
dc.type.originNacionalpt_BR


Thumbnail
   

Este item está licenciado na Creative Commons License

Mostrar registro simples